Patients can expect to lose between 5-15% of their body weight over a period of a few months to a year
Individuals who meet the criteria for Semaglutide GLP-1 treatment, such as having a body mass index (BMI) of 27 or higher and at least one weight-related medical condition, may be prescribed Semaglutide GLP-1 by their healthcare provider
The Bottom Line GLP-1 medications are no longer just weight-loss drugs. They are anti-inflammatory, metabolically active medications that, for the right patients, can meaningfully improve arthritis and autoimmune disease not by replacing your DMARDs or biologics, but by making them work better and protecting your heart along the way
PE-Cy7 anti-mouse CD127 (A7R34, Biolegend), APC-Cy7 anti-mouse CD45 (30-F11, Biolegend), PerCP-eFluor 710 anti-mouse IL-33R/ST2 (RMST2-2, Biolegend)